Paclitaxel protein-bound Intravenous and Conduction disorders
Result of checking the interaction of drug Paclitaxel protein-bound Intravenous and disease Conduction disorders for safety when used together.
When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.
Consumer:Severe conduction abnormalities, some requiring pacemaker placement, have been reported during paclitaxel therapy. Therapy with paclitaxel should be administered cautiously in patients with or predisposed to conduction disorders. Clinical monitoring of cardiac function is recommended during subsequent paclitaxel therapy.
- "Product Information. Taxol (paclitaxel)." Bristol-Myers Squibb, Princeton, NJ.
- Rowinsky EK, Eisenhauer EA, Chaudhry V, Arbuck SG, Donehower RC "Clinical toxicities encountered with paclitaxel (Taxol)." Semin Oncol 20(4 Suppl) (1993): 1-15
Generic Name: paclitaxel protein-bound
Brand Name: Abraxane
Synonyms: Paclitaxel protein-bound, PACLitaxel (Protein Bound)
Paclitaxel protein-bound Intravenous - zaburzenia przewodzenia 
Paclitaxel protein-bound Intravenous - distúrbios de condução 
Paclitaxel protein-bound Intravenous - gangguan konduksi 
Paclitaxel protein-bound Intravenous - gangguan konduksi 
Paclitaxel protein-bound Intravenous - disturbi della conduzione 
Paclitaxel protein-bound Intravenous - troubles de la conduction 
Paclitaxel protein-bound Intravenous - Leitungsstörungen 
Paclitaxel protein-bound Intravenous - trastornos de conducción 
Paclitaxel protein-bound Intravenous - нарушения проводимости 
Paclitaxel protein-bound Intravenous - iletim bozuklukları 
Paclitaxel protein-bound Intravenous - اضطرابات التوصيل 
Paclitaxel protein-bound Intravenous - 传导障碍